icometrix Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
61
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
9
icometrix General Information
Description
Developer of artificial intelligence-based software designed for the analysis of brain magnetic resonance imaging (MRI) images. The company's cloud-based brain magnetic resonance imaging software extracts clinically meaningful information from brain MRI and computed tomography (CT) scans of patients with neurological disorders, enabling medical professionals to improve efficiency in the diagnosis and monitoring of multiple sclerosis.
Contact Information
Website
www.icometrix.comCorporate Office
- Kolonel Begaultlaan 1B box 12
- 3012 Leuven
- Belgium
Corporate Office
- Kolonel Begaultlaan 1B box 12
- 3012 Leuven
- Belgium
icometrix Timeline
icometrix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 06-Jun-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 20-Sep-2024 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 01-Apr-2021 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2020 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 14-May-2019 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 12-Jan-2016 | $2.32M | $2.66M | Completed | Generating Revenue | |
| 1. Early Stage VC | 01-Jan-2011 | $339K | $339K | Completed | Startup |
icometrix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| D Preference | ||||||||
| Preference C | ||||||||
| Class B | ||||||||
| Class A | ||||||||
| Preference C | ||||||||
| Preference C | ||||||||
| Pref | ||||||||
| Pref | ||||||||
| Profit Share C | 35,640 | $3.31 | $3.31 | 1x | $3.31 | 5.57% | ||
| Pref | 29,713 | $5.61 | $5.61 | 1x | $5.61 | 4.64% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
icometrix Comparisons
Industry
Financing
Details
icometrix Competitors (35)
One of icometrix’s 35 competitors is Arterys, a Formerly VC-backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arterys | Formerly VC-backed | San Francisco, CA | ||||
| Advantis Medical Imaging | Venture Capital-Backed | Eindhoven, Netherlands | ||||
| CureMetrix | Venture Capital-Backed | San Diego, CA | ||||
| ImmersiveTouch | Venture Capital-Backed | Chicago, IL | ||||
| HealthMyne | Formerly VC-backed | Madison, WI |
icometrix Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
icometrix Patents
icometrix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4150570-A1 | Computer-implemented method, system and computer program product for determining a vascular function of a perfusion imaging sequence | Active | 13-May-2020 | ||
| AU-2021270979-A1 | Computer-implemented method, system and computer program product for determining a vascular function of a perfusion imaging sequence | Pending | 13-May-2020 | ||
| EP-3910587-A1 | Computer-implemented method, system and computer program product for determining a vascular function of a perfusion imaging sequence | Inactive | 13-May-2020 | ||
| JP-2023525873-A | Computer-implemented method, system and computer program product for determining vascular functions of perfusion imaging sequences | Pending | 13-May-2020 | ||
| US-20240221151-A1 | Computer-implemented method, system and computer program product for determining a vascular function of a perfusion imaging sequence | Pending | 13-May-2020 | G06T7/0012 |
icometrix Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
icometrix Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | |||
| EIT Digital | Accelerator/Incubator | |||
| Forestay Capital | Venture Capital | Minority | ||
| HERAN Partners | Venture Capital | Minority | ||
| Optum Ventures | Corporate Venture Capital | Minority |
icometrix FAQs
-
When was icometrix founded?
icometrix was founded in 2011.
-
Where is icometrix headquartered?
icometrix is headquartered in Leuven, Belgium.
-
What is the size of icometrix?
icometrix has 61 total employees.
-
What industry is icometrix in?
icometrix’s primary industry is Decision/Risk Analysis.
-
Is icometrix a private or public company?
icometrix is a Private company.
-
What is icometrix’s current revenue?
The current revenue for icometrix is .
-
How much funding has icometrix raised over time?
icometrix has raised $24.1M.
-
Who are icometrix’s investors?
MedTech Innovator, EIT Digital, Forestay Capital, HERAN Partners, and Optum Ventures are 5 of 9 investors who have invested in icometrix.
-
Who are icometrix’s competitors?
Arterys, Advantis Medical Imaging, CureMetrix, ImmersiveTouch, and HealthMyne are some of the 35 competitors of icometrix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
